Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer | TheHill – The Hill
Business News
- Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer | TheHill The Hill
- Pfizer recalls Chantix smoking cessation drug for increased cancer risk due to high levels of nitrosamine USA TODAY
- Pfizer recall anti-smoking drug Chantix for high levels nitrosamine, which can increase cancer risk Daily Mail
- Cancer Concerns Lead To ‘Precautionary’ Recall Of Anti-Smoking Drug WJZ
- Cancer concerns lead to ‘precautionary’ recall of anti-smoking drug WKBN.com
- View Full Coverage on Google News
Source: Business News